ID: ALA2315314

Max Phase: Preclinical

Molecular Formula: C10H13N3S2

Molecular Weight: 239.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(C)SSc1nc2ccncc2[nH]1

Standard InChI:  InChI=1S/C10H13N3S2/c1-3-7(2)14-15-10-12-8-4-5-11-6-9(8)13-10/h4-7H,3H2,1-2H3,(H,12,13)

Standard InChI Key:  TWNKNMZDHRKYMV-UHFFFAOYSA-N

Associated Targets(Human)

Thioredoxin 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 239.37Molecular Weight (Monoisotopic): 239.0551AlogP: 3.50#Rotatable Bonds: 4
Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.69CX Basic pKa: 4.97CX LogP: 2.96CX LogD: 2.94
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.83Np Likeness Score: -0.84

References

1. DiRaimondo TR, Plugis NM, Jin X, Khosla C..  (2013)  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.,  56  (3): [PMID:23327656] [10.1021/jm301775s]

Source